Published in Gene Therapy Weekly, May 12th, 2005
"The Rb tumor suppressor pathway is functionally inactivated in most human cancers. In human blood cancers, loss of Rb expression has been widely reported in both acute myeloblastic and acute lymphoblastic leukemias, cyclin D1 amplification is common in mantle cell lymphoma, and silencing of the p16/INK4a tumor suppressor gene occurs frequently in AML and various types of lymphoma," researchers in the United States reported.
"Silencing of p16/INK4A expression is frequently caused by hyper-methylation of CpG islands in its promoter but may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly